The German authorities consider that all criteria mentioned in point 49 of the MSF 2002 guidelines must be fulfilled cumulatively in order to classify Sovello1 and Sovello2 as a single investment project. The German authorities extensively argue this interpretation and base their analysis on the past Commission practice, referring to the Qimonda decision, the Commission decision on AMD [Commission decision of 18 July 2007, N 810/06, Aid to AMD (OJ C 246, 20.10.2007, p. 1).] (hereafter: the AMD decision), and the Commission decision on Q-Cells [Commission decision of 10 July 2007, N 850/06, Aid to Q-Cells (OJ C 270, 13.11.2007, p. 5).] (hereafter: the Q-Cells decision). Since this condition would not be fulfilled in the case of Sovello1 and Sovello2, both projects should be perceived as independent investment projects.
60 5. COMMENTS FROM THE GERMAN AUTHORITIES › 5.2. The investment projects Sovello1 and Sovello2 are independent investments, Decision_act (EU) 2009/697
In forcesince 17 Jun 2009